PYGL and head and neck squamous cell carcinoma: The following experiment confirmed the speculation that PYGL can promote HNSCC’s evolvement by suppressing TP53, which was functionally verified by the discovery that PYGL knock-down resulted in a higher proportion of cells in G0 phase and lower proportion of both G1/S/M and G2 phase.